164 related articles for article (PubMed ID: 27356891)
1. Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes.
Dobbins SE; Broderick P; Chubb D; Kinnersley B; Sherborne AL; Houlston RS
Fam Cancer; 2016 Oct; 15(4):593-9. PubMed ID: 27356891
[TBL] [Abstract][Full Text] [Related]
2. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
[TBL] [Abstract][Full Text] [Related]
3. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS
J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809
[TBL] [Abstract][Full Text] [Related]
4. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
5.
Terradas M; Mur P; Belhadj S; Woodward ER; Burghel GJ; Munoz-Torres PM; Quintana I; Navarro M; Brunet J; Lazaro C; Pineda M; Moreno V; Capella G; Evans DGR; Valle L
Gut; 2021 Jun; 70(6):1139-1146. PubMed ID: 32998877
[TBL] [Abstract][Full Text] [Related]
6. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
[TBL] [Abstract][Full Text] [Related]
7. Novel candidates in early-onset familial colorectal cancer.
Jansen AML; Ghosh P; Dakal TC; Slavin TP; Boland CR; Goel A
Fam Cancer; 2020 Jan; 19(1):1-10. PubMed ID: 31555933
[TBL] [Abstract][Full Text] [Related]
8. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
9. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
10. RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility.
Tavera-Tapia A; de la Hoya M; Calvete O; Martin-Gimeno P; Fernández V; Macías JA; Alonso B; Pombo L; de Diego C; Alonso R; Pita G; Barroso A; Urioste M; Caldés T; Newman JA; Benítez J; Osorio A
Hum Mutat; 2019 May; 40(5):566-577. PubMed ID: 30817846
[TBL] [Abstract][Full Text] [Related]
11. Identification of known and novel familial cancer genes in Swedish colorectal cancer families.
Helgadottir HT; Thutkawkorapin J; Rohlin A; Nordling M; Lagerstedt-Robinson K; Lindblom A
Int J Cancer; 2021 Aug; 149(3):627-634. PubMed ID: 33729574
[TBL] [Abstract][Full Text] [Related]
12. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
Chubb D; Broderick P; Dobbins SE; Frampton M; Kinnersley B; Penegar S; Price A; Ma YP; Sherborne AL; Palles C; Timofeeva MN; Bishop DT; Dunlop MG; Tomlinson I; Houlston RS
Nat Commun; 2016 Jun; 7():11883. PubMed ID: 27329137
[TBL] [Abstract][Full Text] [Related]
13. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
14. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
de Voer RM; Hahn MM; Mensenkamp AR; Hoischen A; Gilissen C; Henkes A; Spruijt L; van Zelst-Stams WA; Kets CM; Verwiel ET; Nagtegaal ID; Schackert HK; van Kessel AG; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
Sci Rep; 2015 Sep; 5():14060. PubMed ID: 26358404
[TBL] [Abstract][Full Text] [Related]
15. Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
Broderick P; Dobbins SE; Chubb D; Kinnersley B; Dunlop MG; Tomlinson I; Houlston RS
Gastroenterology; 2017 Jan; 152(1):75-77.e4. PubMed ID: 27713038
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
17. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
Cybulski C; Lubiński J; Wokołorczyk D; Kuźniak W; Kashyap A; Sopik V; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Górski B; Dębniak T; Narod SA; Akbari MR
Clin Genet; 2015 Oct; 88(4):366-70. PubMed ID: 25330149
[TBL] [Abstract][Full Text] [Related]
18. Identification of Recurrent Variants in
Jiang Y; Tian T; Yu C; Zhou W; Yang J; Wang Y; Wen Y; Chen J; Dai J; Jin G; Ma H; Shen H; Hu Z
Biomed Res Int; 2020; 2020():6739823. PubMed ID: 32879886
[No Abstract] [Full Text] [Related]
19. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
